Notably, it has been suggested that H3R antagonists can enhance cognitive functions in a variety of cognitive disorders by increasing the release of ACh and inducing pGSK-3β [31,32], which is comprehended with our test compound E169 functioning also as an H3 hetero-receptor antagonist. This evidence concerns the gene HRH3 and cognitive disorder.